Accueil / Nouvelles et Évènements


GlycoNet Investigator received McGill’s Principal’s Prize for Public Engagement Through Media

From offering policy advice to sharing his expertise on COVID-19 with the media and public, Dr. Donald Sheppard is recognized a role model with his achievement in engaging with the broader community

GlycoNet and BridgeBio Pharma Inc. initiate collaboration to discover potential treatments for genetic diseases through glycomics research

Genetic disease research has benefitted substantially from the study of glycomics, which relates to the functions of glycans, or sugar, in biological systems

GlycoNet researchers discover how a plaque-fighting protein protects against Alzheimer’s

Research highlights potential pathway for new treatments for neurodegenerative diseases

More stories

  • Tout
  • Prix
  • Communauté
  • Profil du Réseau
  • Communiqué de presse
  • Points saillants de la recherche

GlycoNet Investigator featured in “100 Lives of Insulin” project

Dr. Mike Riddell has spent his career looking at ways to make diabetes easier and safer for those who are living with it. He talks about the why and how behind it.

Canadian Glycomics Network launches Call for Proposals for glycomics projects to address fundamental health challenges in Canada

The Network will commit $1.8 million in glycomics to support made-in-Canada health innovations and build a sustainable national bioeconomy

Canadian company blazes a new trail to drug development

A prime example of Canada’s success in the sub‑sector of the life sciences industry is 48Hour Discovery

Funding research toward treating the root cause of neurodegenerative disease

Professor and GlycoNet Investigator Simonetta Sipione’s research awarded major grant from the Canadian Institutes of Health Research

New radiotracers could be key for new treatments and early detection for Parkinson’s

Nuclear medicine researcher and GlycoNet Investigator Chris Phenix from the University of Saskatchewan has been awarded US$150,000 by The Michael J. Fox Foundation to develop diagnostic radiotracers for early detection of Parkinson’s Disease

Limiting the spread of tuberculosis

GlycoNet researchers are identifying effective ways to prevent one of the top 10 causes of death worldwide

GlycoNet-affiliated start-up 48Hour Discovery and Merck initiate drug discovery project

Project funded through CQDM Quantum Leap program with support from Merck and GlycoNet will exploit new drug development platform

GlycoNet joins BioTalent Canada’s partnership network

Partnership will improve the career prospects in the biotechnology and life sciences sectors in Canada

GlycoNet Investigator named the inaugural recipient of The Legge Orr MI4 Leadership Award

The $1 million donation supports the leadership of Dr. Don Sheppard, Director of McGill Interdisciplinary Initiative in Infection and Immunity (MI4), and will help drive the institute’s mission forward

© Réseau Canadien de la Glycomique (GlycoNet). Tous droits réservés.

Scroll to Top